BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29801597)

  • 21. Characterisation of the faecal metabolome and microbiome of Thoroughbred racehorses.
    Proudman CJ; Hunter JO; Darby AC; Escalona EE; Batty C; Turner C
    Equine Vet J; 2015 Sep; 47(5):580-6. PubMed ID: 25041526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two distinct metacommunities characterize the gut microbiota in Crohn's disease patients.
    He Q; Gao Y; Jie Z; Yu X; Laursen JM; Xiao L; Li Y; Li L; Zhang F; Feng Q; Li X; Yu J; Liu C; Lan P; Yan T; Liu X; Xu X; Yang H; Wang J; Madsen L; Brix S; Wang J; Kristiansen K; Jia H
    Gigascience; 2017 Jul; 6(7):1-11. PubMed ID: 28655159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impact of Exclusive Enteral Nutrition (EEN) on the Gut Microbiome in Crohn's Disease: A Review.
    MacLellan A; Moore-Connors J; Grant S; Cahill L; Langille MGI; Van Limbergen J
    Nutrients; 2017 May; 9(5):. PubMed ID: 28468301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosa-Associated Ileal Microbiota in New-Onset Pediatric Crohn's Disease.
    Assa A; Butcher J; Li J; Elkadri A; Sherman PM; Muise AM; Stintzi A; Mack D
    Inflamm Bowel Dis; 2016 Jul; 22(7):1533-9. PubMed ID: 27271491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-time monitoring of exhaled volatiles using atmospheric pressure chemical ionization on a compact mass spectrometer.
    Heaney LM; Ruszkiewicz DM; Arthur KL; Hadjithekli A; Aldcroft C; Lindley MR; Thomas CP; Turner MA; Reynolds JC
    Bioanalysis; 2016 Jul; 8(13):1325-36. PubMed ID: 27277875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis.
    van Mastrigt E; Reyes-Reyes A; Brand K; Bhattacharya N; Urbach HP; Stubbs AP; de Jongste JC; Pijnenburg MW
    J Breath Res; 2016 Apr; 10(2):026003. PubMed ID: 27058305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air.
    Meyer N; Dallinga JW; Nuss SJ; Moonen EJ; van Berkel JJ; Akdis C; van Schooten FJ; Menz G
    Respir Res; 2014 Nov; 15(1):136. PubMed ID: 25431084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia.
    Schnabel R; Fijten R; Smolinska A; Dallinga J; Boumans ML; Stobberingh E; Boots A; Roekaerts P; Bergmans D; van Schooten FJ
    Sci Rep; 2015 Nov; 5():17179. PubMed ID: 26608483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn's Disease.
    Galazzo G; Tedjo DI; Wintjens DSJ; Savelkoul PHM; Masclee AAM; Bodelier AGL; Pierik MJ; Jonkers DMAE; Penders J
    J Crohns Colitis; 2019 Sep; 13(10):1273-1282. PubMed ID: 30810207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Microbiome in Paediatric Crohn's Disease-A Longitudinal, Prospective, 
Single-Centre Study.
    Kansal S; Catto-Smith AG; Boniface K; Thomas S; Cameron DJ; Oliver M; Alex G; Kirkwood CD; Wagner J
    J Crohns Colitis; 2019 Aug; 13(8):1044-1054. PubMed ID: 30927743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative microbiome profiling links gut community variation to microbial load.
    Vandeputte D; Kathagen G; D'hoe K; Vieira-Silva S; Valles-Colomer M; Sabino J; Wang J; Tito RY; De Commer L; Darzi Y; Vermeire S; Falony G; Raes J
    Nature; 2017 Nov; 551(7681):507-511. PubMed ID: 29143816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of gender-specific exhaled breath volatome in humans by GCxGC-TOF-MS.
    Das MK; Bishwal SC; Das A; Dabral D; Varshney A; Badireddy VK; Nanda R
    Anal Chem; 2014 Jan; 86(2):1229-37. PubMed ID: 24350824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma.
    Kumar S; Huang J; Abbassi-Ghadi N; Mackenzie HA; Veselkov KA; Hoare JM; Lovat LB; Španěl P; Smith D; Hanna GB
    Ann Surg; 2015 Dec; 262(6):981-90. PubMed ID: 25575255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD.
    De Preter V; Machiels K; Joossens M; Arijs I; Matthys C; Vermeire S; Rutgeerts P; Verbeke K
    Gut; 2015 Mar; 64(3):447-58. PubMed ID: 24811995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individualized Dynamics in the Gut Microbiota Precede Crohn's Disease Flares.
    Braun T; Di Segni A; BenShoshan M; Neuman S; Levhar N; Bubis M; Picard O; Sosnovski K; Efroni G; Farage Barhom S; Glick Saar E; Lahad A; Weiss B; Yablecovitch D; Lahat A; Eliakim R; Kopylov U; Ben-Horin S; Haberman Y
    Am J Gastroenterol; 2019 Jul; 114(7):1142-1151. PubMed ID: 30741738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study.
    Nizio KD; Perrault KA; Troobnikoff AN; Ueland M; Shoma S; Iredell JR; Middleton PG; Forbes SL
    J Breath Res; 2016 Apr; 10(2):026008. PubMed ID: 27120170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.